Nihon Medi-Physics Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nihon Medi-Physics Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5325
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nihon Medi-Physics Co Ltd (NMCL), a subsidiary of Sumitomo Chemical Co Ltd, is a radioactive pharmaceuticals and radioactive medical device manufacturer. The company offers research, development, production, sale, purchase and import and export of radioactive pharmaceuticals, medical devices and related products. Its business fields include SPECT diagnostics business, PET diagnostic business and radiotherapy business. NMCL’s single photon emission computed tomography is a nuclear medicine that uses small amounts of radioisotopes combined with medical devices or pharmaceuticals for diagnostic or therapeutic applications. The company partner with academic societies and technology centre. It operates in Tokyo, Amagasa, Sodegaura and Sanda, Japan. NMCL is headquartered in Tokyo, Japan.

Nihon Medi-Physics Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nihon Medi-Physics Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Telix Pharma and Nihon Medi-Physics to Enter into Partnership 11
Eisai Enters into Agreement with Nihon Medi-Physics 12
Licensing Agreements 13
Endocyte Enters into Licensing Agreement with Nihon Medi-Physics for Etarfolatide 13
Nihon Medi-Physics Co Ltd – Key Competitors 14
Nihon Medi-Physics Co Ltd – Key Employees 15
Nihon Medi-Physics Co Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nihon Medi-Physics Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Nihon Medi-Physics Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Telix Pharma and Nihon Medi-Physics to Enter into Partnership 11
Eisai Enters into Agreement with Nihon Medi-Physics 12
Endocyte Enters into Licensing Agreement with Nihon Medi-Physics for Etarfolatide 13
Nihon Medi-Physics Co Ltd, Key Competitors 14
Nihon Medi-Physics Co Ltd, Key Employees 15
Nihon Medi-Physics Co Ltd, Other Locations 16
Nihon Medi-Physics Co Ltd, Joint Venture 16

List of Figures
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nihon Medi-Physics Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nihon Medi-Physics Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Nihon Medi-Physics Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of Texas Southwestern Medical Center-医療機器分野:企業M&A・提携分析
    Summary University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System is an educational center that offers medical research and education programs. The center offers degree programs, which include master's degree in business administration, public health, medica …
  • Leidos Holdings Inc:企業の戦略・SWOT・財務情報
    Leidos Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Leidos Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Danubius Hotel And Spa Private Company Limited
    Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report Summary Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Ipsen S.A.:企業の戦略・SWOT・財務情報
    Ipsen S.A. - Strategy, SWOT and Corporate Finance Report Summary Ipsen S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sky plc (SKY):企業の財務・戦略的SWOT分析
    Sky plc (SKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Demir-Halkbank (Nederland) N.V.:企業の戦略・SWOT・財務情報
    Demir-Halkbank (Nederland) N.V. - Strategy, SWOT and Corporate Finance Report Summary Demir-Halkbank (Nederland) N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Banyan Biomarkers Inc:企業の製品パイプライン分析2018
    Summary Banyan Biomarkers Inc (Banyan Biomarkers) is a medical technology company that commercializes vitro diagnostic tests for the detection of traumatic brain injury and neurological diseases. The company’s product pipeline includes biomarkers for depression, hypoxic ischemic encephalopathy, neur …
  • Japan Airlines Co Ltd:企業のM&A・事業提携・投資動向
    Japan Airlines Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Japan Airlines Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Vortex Energy Holding AG:電力:M&Aディール及び事業提携情報
    Summary Vortex Energy Holding AG (Vortex Energy) is a provider of renewable energy services. The company's services include development, consulting, financing, planning, implementation, construction, technical management, technical inspection, commercial management, and energy trading services. It a …
  • MidAmerican Energy Co:電力:M&Aディール及び事業提携情報
    Summary MidAmerican Energy Company (MidAmerican Energy), a subsidiary of Berkshire Hathaway Energy, is a regulated electric and natural gas utility company that carries out the generation, transmission and distribution and selling of electricity. The company also undertakes distribution, selling and …
  • Groupe SMCP S.A.S.:企業の戦略的SWOT分析
    Groupe SMCP S.A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Fred Hutchinson Cancer Research Center:企業のM&A・事業提携・投資動向
    Fred Hutchinson Cancer Research Center - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fred Hutchinson Cancer Research Center Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Shionogi Inc:企業の戦略的SWOT分析
    Shionogi Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Premaitha Health Plc (NIPT)-製薬・医療分野:企業M&A・提携分析
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • Suheung Capsule Co Ltd (008490):企業の財務・戦略的SWOT分析
    Suheung Capsule Co Ltd (008490) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Ipsen Biopharmaceuticals Inc:企業の戦略的SWOT分析
    Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Sprint Bioscience AB (SPRINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sprint Bioscience AB (Sprint Bioscience) is a developer of pharmaceutical products in the areas of cancer and metabolism. The company develops STK25, a drug candidate against a new target protein for the treatment of type 2 diabetes; VPS34, a drug candidate for the treatment of various types …
  • Bahrain Telecommunications Company BSC (BATELCO):企業の戦略的SWOT分析
    Bahrain Telecommunications Company BSC (BATELCO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • The Lubrizol Corp:企業の戦略的SWOT分析
    The Lubrizol Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Xped Limited (XPE)-エネルギー分野:企業M&A・提携分析
    Summary Xped Limited (Xped) formerly Raya Group Limited, is an Internet of Things company that develops software and hardware solutions. It offers auto discovery remote control, Xerts, and Xped app software; and hardware such as Xped ADRC Shields, Umbo-Xped ADRC Hub, UltraPlug, VariPlug, IRBlaster. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆